Quantification of 5-methylcytosine and 5-hydroxymethylcytosine in genomic DNA from hepatocellular carcinoma tissues by capillary hydrophilic-interaction liquid chromatography/quadrupole TOF mass spectrometry.
about
Multiple Functions of Ten-eleven Translocation 1 during TumorigenesisRegulation of the Epigenome by Vitamin CEmerging technologies for studying DNA methylation for the molecular diagnosis of cancerAssociation of 5-methylcytosine and 5-hydroxymethylcytosine with mitochondrial DNA content and clinical and biochemical parameters in hepatocellular carcinomaDecreased N(6)-methyladenosine in peripheral blood RNA from diabetic patients is associated with FTO expression rather than ALKBH5High expression of 5-hydroxymethylcytosine and isocitrate dehydrogenase 2 is associated with favorable prognosis after curative resection of hepatocellular carcinoma.Tet-mediated formation of 5-hydroxymethylcytosine in RNA.Quantitative mass spectrometry-based analysis of β-D-glucosyl-5-hydroxymethyluracil in genomic DNA of Trypanosoma brucei.Effects of Tet-mediated oxidation products of 5-methylcytosine on DNA transcription in vitro and in mammalian cells.Mutagenic and cytotoxic properties of oxidation products of 5-methylcytosine revealed by next-generation sequencing.Detection of oxidation products of 5-methyl-2'-deoxycytidine in Arabidopsis DNA.Genome-wide assays that identify and quantify modified cytosines in human disease studiesRRHP: a tag-based approach for 5-hydroxymethylcytosine mapping at single-site resolutionDNA hydroxymethylation age of human blood determined by capillary hydrophilic-interaction liquid chromatography/mass spectrometry.Associations of ChREBP and Global DNA Methylation with Genetic and Environmental Factors in Chinese Healthy AdultsSensitive Determination of Onco-metabolites of D- and L-2-hydroxyglutarate Enantiomers by Chiral Derivatization Combined with Liquid Chromatography/Mass Spectrometry Analysis.Cancer as a dysregulated epigenome allowing cellular growth advantage at the expense of the hostTET-catalyzed 5-hydroxymethylcytosine regulates gene expression in differentiating colonocytes and colon cancerLoss of 5-hydroxymethylcytosine is linked to gene body hypermethylation in kidney cancerAssociation of global DNA hypomethylation with clinicopathological variables in colonic tumors of Iraqi patients.Interplay between Metabolism and Epigenetics: A Nuclear Adaptation to Environmental Changes.The hypomethylating agent Decitabine causes a paradoxical increase in 5-hydroxymethylcytosine in human leukemia cellsAlterations of 5-hydroxymethylcytosine in human cancers.Urinary Measurement of Epigenetic DNA Modifications: A Non-Invasive Assessment of the Whole-Body Epigenetic Status in Healthy Subjects and Colorectal Cancer Patients.Iron Supplementation Reverses the Reduction of Hydroxymethylcytosine in Hepatic DNA Associated With Chronic Alcohol Consumption in Rats.Technical advances in global DNA methylation analysis in human cancers.Recent advances in the bioanalysis of modified nucleotides in epigenetic studies.5-hydroxymethylcytosine: a potential therapeutic target in cancer.Monoliths in capillary electrochromatography and capillary liquid chromatography in conjunction with mass spectrometry.Evaluation of wild yam (Dioscorea villosa) root extract as a potential epigenetic agent in breast cancer cells.Epigenetic modification of nucleic acids: from basic studies to medical applications.Oxygen nanobubbles revert hypoxia by methylation programming.Altered hydroxymethylation is seen at regulatory regions in pancreatic cancer and regulates oncogenic pathways.Absolute and relative quantification of RNA modifications via biosynthetic isotopomers.Selective inhibition of CTCF binding by iAs directs TET-mediated reprogramming of 5-hydroxymethylation patterns in iAs-transformed cells.Global changes of 5-hydroxymethylcytosine and 5-methylcytosine from normal to tumor tissues are associated with carcinogenesis and prognosis in colorectal cancer*.TET1-Mediated Oxidation of 5-Formylcytosine (5fC) to 5-Carboxycytosine (5caC) in RNA.Genomic 5-mC contents in peripheral blood leukocytes were independent protective factors for coronary artery disease with a specific profile in different leukocyte subtypes.The existence of 5-hydroxymethylcytosine and 5-formylcytosine in both DNA and RNA in mammals.Hepatic DNA hydroxymethylation is site-specifically altered by chronic alcohol consumption and aging.
P2860
Q26740522-92BDDAED-6F1F-4C5E-AD64-A1BFD830856BQ27000867-07C4302B-A29A-4E7C-A673-D820C6685241Q28087759-62DF9888-E41B-405A-8B52-67DA8E91D52CQ28534409-679B87F6-A51B-46BB-A02A-449BA72D8548Q33587864-E563C24A-B9CF-4C6D-B31C-7A8793C03092Q33845409-A8E76FAE-446B-432C-833F-3A9AB2C68F97Q34074616-9A725045-C8F7-4FF2-BA20-B0F59F913B1AQ34175560-AEB64B83-7596-43BC-AA76-86486032C89FQ34507760-AD9097D5-A31E-47D4-95DD-5986D24ACC98Q34996918-B6BBB365-2E49-4DBB-BA93-E30C151210F1Q35083019-9F172AE6-9367-44E7-AC12-DD80A8DACA78Q35187229-BDD20503-AF88-4BE4-B338-D664F6D61EB4Q35271908-437C0020-DD10-4662-BA8D-06A719EB9B7AQ35881101-558424EE-0033-4D1E-A98A-6C36635EF2E9Q36047040-A3B5E199-0249-4C74-B14B-496A97ADA6A9Q36150279-D286C9B0-7495-46C6-8517-9B638E6B3CFAQ36257990-9913BCB2-2B19-431A-9AE0-88F395C11CD0Q36343320-374605E8-6E24-4534-86D6-538A35C3C756Q36751646-72A420A6-7B1D-494A-9289-C2E17BFB764CQ36755452-7BD73449-D5D7-4C9C-BE5B-43CE08E12D8CQ36969070-0EC27AD7-3EDD-440D-966C-A37205D39BF2Q36972667-46903322-49E3-447B-B5D2-6F62251E604AQ37226486-AC2FF55E-48CD-4842-9BF6-29DB2727C281Q37515289-981C44ED-8B47-4A0B-8528-882BDB3C4DE6Q37552321-6B1D5B84-F5AC-4038-9D25-9274F3BE4AA8Q37673323-394F912F-3EB9-48FE-8C4E-8EC56941F250Q38167832-0BFB3949-714B-4C87-A89E-DB15174D20CBQ38272312-C720B4B0-7721-4C65-9358-8D96FA06E952Q38708025-D8433217-D230-4F0A-8039-8973AE0A7C5EQ38963653-53D36E52-A9CE-44AE-A5BE-540EF8292FD4Q39206156-B00DB607-2958-40B3-8E4E-DEDFC822C5C8Q41516085-D84000BF-B27F-4781-8CF5-BCCAE9EC366EQ42778048-DCB2569E-E028-4276-9BA9-3F8AA8EEAC94Q42937335-8C6CCA4B-6924-4DFB-83DB-15CE2F9DB4B1Q47116981-28CCF4A0-9379-4B2E-9881-9E901E0AF207Q47160634-AED1E1BD-C334-41F5-AF7F-F42F60BE06E4Q48252802-C64B2656-8595-491B-8801-21875B8531EBQ49271010-CEBAD7B1-C514-4D1B-BC10-439340DEC86BQ50913128-1820685A-42FB-4C7C-8591-4A0738FAED62Q51476305-5488E826-A98E-4BA0-9854-3BF19DD551A8
P2860
Quantification of 5-methylcytosine and 5-hydroxymethylcytosine in genomic DNA from hepatocellular carcinoma tissues by capillary hydrophilic-interaction liquid chromatography/quadrupole TOF mass spectrometry.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 23 January 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Quantification of 5-methylcyto ...... drupole TOF mass spectrometry.
@en
Quantification of 5-methylcyto ...... drupole TOF mass spectrometry.
@nl
type
label
Quantification of 5-methylcyto ...... drupole TOF mass spectrometry.
@en
Quantification of 5-methylcyto ...... drupole TOF mass spectrometry.
@nl
prefLabel
Quantification of 5-methylcyto ...... drupole TOF mass spectrometry.
@en
Quantification of 5-methylcyto ...... drupole TOF mass spectrometry.
@nl
P2093
P2860
P1433
P1476
Quantification of 5-methylcyto ...... adrupole TOF mass spectrometry
@en
P2093
Jia-Hui Qi
Ming-Luan Chen
Song-Mei Liu
Yinsheng Wang
P2860
P304
P356
10.1373/CLINCHEM.2012.193938
P407
P577
2013-01-23T00:00:00Z